CureVac, the newest experimental coronavirus vaccine, proves simply 48 p.c efficient total, a disappointing consequence

CureVac, the newest experimental coronavirus vaccine, proves simply 48 p.c efficient total, a disappointing consequence

CureVac, whose vaccine comes with simpler storage necessities than different mRNA pictures, laid out a potential path to salvage its vaccine, emphasizing its utility in folks 18 to 60 years outdated. In that age group, total efficacy was 53 p.c, with a lot stronger safety towards reasonable and extreme instances of sickness. For folks in that group, it fully protected towards hospitalization and demise, and supplied 77 p.c safety towards reasonable and extreme instances.

Source link